| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $0.2337 (Miss by $-0.5563) |
| EPS GAAP Actual | $0.2337 (Miss by $-0.5563) |
| Revenue Actual | $0.400224B |
| Revenue Surprise | Beat by $400.224M |
| Announce Date | 03/29/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.072081 |
| EPS GAAP Estimate | $-0.072081 |
| Revenue Estimate | $0.257479179B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 0 | INF | 0 | 0 | 0 |
| Dec 2026 | 1.89542 | 18.58 | 1.87431 | 1.91653 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.23 | 0.23 | 0.400224B | 7.89% | 400.22M |
| FQ2 2025 (Jun 2025) | 0 | 0 | 0.524156B | 4.76% | 524.16M |
| FQ1 2025 (Mar 2025) | -0.13 | -0.13 | 0.236162B | 99.88% | 236.16M |
| FQ4 2024 (Dec 2024) | 0.62 | 0.62 | 0.423394B | 3.3% | 423.39M |
| FQ3 2024 (Sep 2024) | 0.56 | 0.56 | 0.368631B | 1.93% | 368.63M |
| FQ2 2024 (Jun 2024) | 0 | 0 | 0.4992B | 7.43% | 499.2M |
| FQ1 2024 (Mar 2024) | 0 | 0 | 0.0002754B | -91149.09% | 0.28M |
| FQ1 2014 (Mar 2014) | -0.0636 | -0.0636 | 1.05831B | 100% | 1058.31M |
FQ4 Announce Date
03/29/2026 (Pre-Market)
Consensus EPS Estimates
-0.072081
Consensus Revenue Estimates
0.257479179B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.89867 | -- | 0.88468 | 0.91646 | 1 |
| FQ3 2027 (Sep 2027) | 0.44246 | -- | 0.43557 | 0.45122 | 1 |
| FQ2 2027 (Jun 2027) | 1.03646 | -- | 1.02033 | 1.05698 | 1 |
| FQ1 2027 (Mar 2027) | -0.033596 | -- | -0.03426104 | -0.03307314 | 1 |
| FQ4 2026 (Dec 2026) | 0.84645 | -- | 0.83328 | 0.86321 | 1 |
| FQ3 2026 (Sep 2026) | 0.34986 | 34.26 | 0.34442 | 0.35679 | 1 |
| FQ2 2026 (Jun 2026) | 0.91548 | -- | 0.90123 | 0.9336 | 1 |
| FQ1 2026 (Mar 2026) | -0.072081 | -80.35 | -0.07350786 | -0.07095919 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.59B | -- | 0.59B | 0.6B | 1 |
| FQ3 2027 (Sep 2027) | 0.47B | -- | 0.47B | 0.48B | 1 |
| FQ2 2027 (Jun 2027) | 0.64B | -- | 0.63B | 0.65B | 1 |
| FQ1 2027 (Mar 2027) | 0.28B | -- | 0.28B | 0.29B | 1 |
| FQ4 2026 (Dec 2026) | 0.55B | -- | 0.54B | 0.56B | 1 |
| FQ3 2026 (Sep 2026) | 0.43B | 6.76 | 0.42B | 0.44B | 1 |
| FQ2 2026 (Jun 2026) | 0.57B | 7.81 | 0.56B | 0.58B | 1 |
| FQ1 2026 (Mar 2026) | 0.26B | 8.28 | 0.25B | 0.26B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
2
EPS # of in-lines
3
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.23 | 0.23 | 100% | |
| FQ2 2025 (Jun 2025) | 0 | 0 | NAN% | |
| FQ1 2025 (Mar 2025) | -0.13 | -0.13 | 100% | |
| FQ4 2024 (Dec 2024) | 0.62 | 0.62 | 100% | |
| FQ3 2024 (Sep 2024) | 0.56 | 0.56 | 100% | |
| FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
| FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
| FQ1 2014 (Mar 2014) | -0.0636 | -0.0636 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.4B | $400.22M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.52B | $524.16M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.24B | $236.16M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.42B | $423.39M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.37B | $368.63M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.5B | $499.2M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0B | $0.28M | 100% |
| FQ1 2014 (Mar 2014) | $0B | $1.06B | $1058.31M | 100% |